Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 2,053

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Third universal definition of myocardial infarction

the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen, Kristian, Alpert, Joseph S., Jaffe, Allan S., Simoons, Maarten L., Chaitman, Bernard R., White, Harvey D.·2012·Nature Reviews Cardiology
DOI 10.1038/nrcardio.2012.122
Open this paper in CoChat — free account

Abstract

Authors/Task Force Members Chairpersons: Kristian Thygesen (Denmark)*, Joseph S. Alpert, (USA)*, Harvey D. White, (New Zealand)*, Biomarker Subcommittee: Allan S. Jaffe (USA), Hugo A. Katus (Germany), Fred S. Apple (USA), Bertil Lindahl (Sweden), David A. Morrow (USA), ECG Subcommittee: Bernard R. Chaitman (USA), Peter M. Clemmensen (Denmark), Per Johanson (Sweden), Hanoch Hod (Israel), Imaging Subcommittee: Richard Underwood (UK), Jeroen J. Bax (The Netherlands), Robert O. Bonow (USA), Fausto Pinto (Portugal), Raymond J. Gibbons (USA), Classification Subcommittee: Keith A. Fox (UK), Dan Atar (Norway), L. Kristin Newby (USA), Marcello Galvani (Italy), ChristianW. Hamm (Germany), Intervention Subcommittee: Barry F. Uretsky (USA), Ph. Gabriel Steg (France), William Wijns (Belgium), Jean-Pierre Bassand (France), Phillippe Menasche (France), Jan Ravkilde (Denmark), Trials & Registries Subcommittee: E. Magnus Ohman (USA), Elliott M. Antman (USA), Lars C. Wallentin (Sweden), Paul W. Armstrong (Canada), Maarten L. Simoons (The Netherlands), Heart Failure Subcommittee: James L. Januzzi (USA), Markku S. Nieminen (Finland), Mihai Gheorghiade (USA), Gerasimos Filippatos (Greece), Epidemiology Subcommittee: Russell V. Luepker (USA), Stephen P. Fortmann (USA), Wayne D. Rosamond (USA), Dan Levy (USA), David Wood (UK), Global Perspective Subcommittee: Sidney C. Smith (USA), Dayi Hu (China), José-Luis Lopez-Sendon (Spain), Rose Marie Robertson (USA), Douglas Weaver (USA), Michal Tendera (Poland), Alfred A. Bove (USA), Alexander N. Parkhomenko (Ukraine), Elena J. Vasilieva (Russia), Shanti Mendis (Switzerland).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrcardio.2012.122

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 100

  1. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur. Heart J. 21, 1502–1513; J. Am. Coll. Cardiol. 36, 959–969 (2000). · DOI · Paper page
  2. Thygesen, K., Alpert, J. S., White, H. D., Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur. Heart J. 28, 2525–2538; Circulation 116, 2634–2653; J. Am. Coll. Cardiol. 50, 2173–2195 (2007). · DOI · Paper page
  3. Mendis, S. et al. on behalf of the participating experts of the WHO consultation for revision of WHO definition of myocardial infarction. World Health Organization definition of myocardial infarction: 2008–09 revision. Int. J. Epidemiol. 40, 139–146 (2011). · DOI · Paper page
  4. Jennings, R. B. & Ganote, C. E. Structural changes in myocardium during acute ischemia. Circ. Res. 35 (Suppl. 3), 156–172 (1974).
  5. Jaffe, A. S., Babuin, L. & Apple, F. S. Biomarkers in acute cardiac disease. J. Am. Coll. Cardiol. 48, 1–11 (2006). · DOI · Paper page
  6. White, H. D. Pathobiology of troponin elevations. J. Am. Coll. Cardiol. 57, 2406–2408 (2011). · DOI · Paper page
  7. Jaffe, A. S. Chasing troponin: how low can you go if you can see the rise? J. Am. Coll. Cardiol. 48, 1763–1764 (2006). · DOI
  8. Apple, F. S., Jesse, R. L., Newby, L. K., Wu, A. H. B. & Christenson, R. H. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 115, e352–e355 (2007).
  9. Morrow, D. A. et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers of acute coronary syndromes. Circulation 115, e356–e375 (2007). · DOI · Paper page
  10. Thygesen, K. et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur. Heart J. 31, 2197–2204 (2010). · DOI · Paper page
  11. Thygesen, K. et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/ehs154 . · DOI · Paper page
  12. Jaffe, A. S., Apple, F. S., Morrow, D. A., Lindahl, B. & Katus, H. A. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin. Chem. 56, 941–943 (2010). · DOI
  13. MacRae, A. R. et al. Assessing the requirement for the six-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin. Chem. 52, 812–818 (2006). · DOI
  14. de Lemos, J. A. et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 304, 2503–2512 (2010). · DOI · Paper page
  15. Omland, T. et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N. Engl. J. Med. 361, 2538–2547 (2009). · DOI · Paper page
  16. Mills, N. L. et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 305, 1210–1216 (2011). · DOI · Paper page
  17. Saunders, J. T. et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation 123, 1367–1376 (2011). · DOI · Paper page
  18. Kavsak, P. A., Xu, L., Yusuf, S. & McQueen, M. J. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin. Chem. 57, 1146–1153 (2011). · DOI
  19. Apple, F. S., Simpson, P. A. & Murakami, M. M. Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay. Clin. Biochem. 43, 1034–1036 (2010). · DOI
  20. Giannitsis, E. et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin. Chem. 56, 254–261 (2010). · DOI · Paper page
  21. Apple, F. S., Quist, H. E., Doyle, P. J., Otto, A. P. & Murakami, M. M. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin. Chem. 49, 1331–1336 (2003). · DOI · Paper page
  22. Roe, M. T. et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease. The Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial investigators. Circulation 102, 1101–1106 (2000). · DOI · Paper page
  23. Bugiardini, R., Manfrini, O. & De Ferrari, G. M. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch. Intern. Med. 166, 1391–1395 (2006). · DOI · Paper page
  24. Reynolds, H. R. et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 124, 1414–1425 (2011). · DOI · Paper page
  25. Bertrand, M. E. et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 65, 1299–1306 (1982). · DOI · Paper page
  26. Suwaidi, J. A. et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101, 948–954 (2000). · DOI · Paper page
  27. Bugiardini, R., Manfrini, O., Pizzi, C., Fontana, F. & Morgagni, G. Endothelial function predicts future development of coronary artery disease: a study on women with chest pain and normal angiograms. Circulation 109, 2518–2523 (2004). · DOI · Paper page
  28. Harris, B. M., Nageh, T., Marsden, J. T., Thomas, M. R. & Sherwood, R. A. Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures. Ann. Clin. Biochem. 37, 764–769 (2000). · DOI
  29. Januzzi, J. L. et al. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J. Am. Coll. Cardiol. 39, 1518–1523 (2002). · DOI · Paper page
  30. Holmvang, L. et al. Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery. Chest 121, 103–111 (2002). · DOI
  31. Miller, W. L., Garratt, K. N., Burritt, M. F., Reeder, G. S. & Jaffe, A. S. Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention. Chest 25, 275–280 (2004). · DOI
  32. Lansky, A. J. & Stone, G. W. Periprocedural myocardial infarction: prevalence, prognosis, and prevention. Circ. Cardiovasc. Interv. 3, 602–610 (2010). · DOI · Paper page
  33. Cavallini, C. et al. Prognostic value of isolated troponin I elevation after percutaneous coronary intervention. Circ. Cardiovasc. Interv. 3, 431–435 (2010). · DOI
  34. Prasad, A. Jr. et al. Significance of periprocedural myonecrosis on outcomes following percutaneous coronary intervention. Circ. Cardiovasc. Interv. 1, 10–19 (2008). · DOI · Paper page
  35. Zimetbaum, P. J. & Josephson, M. E. Use of the electrocardiogram in acute myocardial infarction. N. Engl. J. Med. 348, 933–940 (2003). · DOI · Paper page
  36. Wang, K., Asinger, R. W. & Marriott, H. J. ST-segment elevation in conditions other than acute myocardial infarction. N. Engl. J. Med. 349, 2128–2135 (2003). · DOI · Paper page
  37. Mcfarlane, P. W. Age, sex, and the ST amplitude in health and disease. J. Electrocardiol. 34 (Suppl.), S35–S41 (2001).
  38. Zimetbaum, P. J., Krishnan, S., Gold, A., Carrozza, J. P. 2nd & Josephson, M. E. Usefulness of ST-segment elevation in lead III exceeding that of lead II for identifying the location of the totally occluded coronary artery in inferior wall myocardial infarction. Am. J. Cardiol. 81, 918–919 (1998). · DOI
  39. Engelen, D. J. et al. Value of the electrocardiogram in localizing the occlusion site in the left anterior descending coronary artery in acute anterior myocardial infarction. J. Am. Coll. Cardiol. 34, 389–395 (1999). · DOI · Paper page
  40. Matetzky, S. et al. Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7–V9. Hidden ST-segment elevations revealing acute posterior infarction. J. Am. Coll. Cardiol. 34, 748–753 (1999). · DOI
  41. Lopez-Sendon, J., Coma-Canella, I., Alcasena, S., Seoane, J. & Gamallo, C. Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2 and V3 . J. Am. Coll. Cardiol. 6, 1273–1279 (1985). · DOI · Paper page
  42. Bayés de Luna, A. et al. A new terminology for the left ventricular walls and for the location of myocardial infarcts that present Q. wave based on the standard of cardiac magnetic resonance imaging. A statement for healthcare professionals from a Committee appointed by the International Society for Holter and Noninvasive Electrocardiography. Circulation 114, 1755–1760 (2006). · DOI · Paper page
  43. Sgarbossa, E. B. et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle branch block. N. Engl. J. Med. 334, 481–487 (1996). · DOI · Paper page
  44. Jain, S. et al. Utility of left bundle branch block as a diagnostic criterion for acute myocardial infarction. Am. J. Cardiol. 107, 1111–1116 (2011). · DOI
  45. Savage, R. M., Wagner, G. S., Ideker, R. E., Podolsky, S. A. & Hackel, D. B. Correlation of postmortem anatomic findings with electrocardiographic changes in patients with myocardial infarction: retrospective study of patients with typical anterior and posterior infarcts. Circulation 55, 279–285 (1977). · DOI · Paper page
  46. Horan, L. G., Flowers, N. C. & Johnson, J. C. Significance of the diagnostic Q wave of myocardial infarction. Circulation 43, 428–436 (1971). · DOI · Paper page
  47. Burgess, D. C. et al. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur. Heart J. 31, 92–99 (2010). · DOI · Paper page
  48. Sheifer, S. E., Manolio, T. A. & Gersh, B. J. Unrecognized myocardial infarction. Ann. Intern. Med. 135, 801–811 (2001). · DOI · Paper page
  49. Toma, M. et al. Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am. Heart J. 160, 671–677 (2010). · DOI
  50. Stillman, A. E. et al. Assessment of acute myocardial infarction: current status and recommendations from the North American Society for Cardiovascular Imaging and the European Society of Cardiac Radiology. Int. J. Cardiovasc. Imaging 27, 7–24 (2011). · DOI
  51. Flachskampf, F. A. et al. Cardiac imaging after myocardial infarction. Eur. Heart J. 32, 272–283 (2011). · DOI
  52. Kaul, S. et al. A suggested roadmap for cardiovascular ultrasound research for the future. J. Am. Soc. Echocardiogr. 24, 455–464 (2011). · DOI
  53. Carrio, I., Cowie, M. R., Yamazaki, J., Udelson, J. & Camici, P. G. Cardiac sympathetic imaging with mIBG in heart failure. JACC Imaging 3, 92–100 (2010). · DOI · Paper page
  54. Nahrendorf, M. et al. Multimodality cardiovascular molecular imaging, part II. Circ. Cardiovasc. Imaging 2, 56–70 (2009). · DOI
  55. Kramer, C. M., Sinusas, A. J., Sosnovik, D. E., French, B. A. & Bengel, F. M. Multimodality imaging of myocardial injury and remodeling. J. Nucl. Med. 51 (Suppl. 1), 107S–121S (2010). · DOI
  56. Taegtmeyer, H. Tracing cardiac metabolism in vivo: one substrate at a time. J. Nucl. Med. 51 (Suppl. 1), 80S–87S (2010). · DOI
  57. Kim, H. W., Faraneh-Far, A. & Kim, R. J. Cardiovascular magnetic resonance in patients with myocardial infarction. J. Am. Coll. Cardiol. 55, 1–16 (2010). · DOI · Paper page
  58. Beek, A. M. & van Rossum, A. C. Cardiovascular magnetic resonance imaging in patients with acute myocardial infarction. Heart 96, 237–243 (2010). · DOI
  59. Assomull, R. G. et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur. Heart J. 28, 1242–1249 (2007). · DOI · Paper page
  60. Schuleri, K. H., George, R. T. & Lardo, A. C. Assessment of coronary blood flow with computed tomography and magnetic resonance imaging. J. Nucl. Cardiol. 17, 582–590 (2010). · DOI
  61. Amsterdam, E. A. et al. Testing of low-risk patients presenting to the emergency department with chest pain. Circulation 122, 1756–1776 (2010). · DOI · Paper page
  62. Gibbons, R. J., Valeti, U. S., Araoz, P. A. & Jaffe, A. S. The quantification of infarct size. J. Am. Coll. Cardiol. 44, 1533–1542 (2004). · DOI · Paper page
  63. Herrman, J. Peri-procedural myocardial injury: 2005 update. Eur. Heart J. 26, 2493–2519 (2005). · DOI · Paper page
  64. Selvanayagam, J. B. et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 111, 1027–1032 (2005). · DOI · Paper page
  65. Gustavsson, C. G., Hansen, O. & Frennby, B. Troponin must be measured before and after PCI to diagnose procedure-related myocardial injury. Scand. Cardiovasc. J. 38, 75–79 (2004). · DOI
  66. Miller, W. L. et al. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur. Heart J. 27, 1061–1069 (2006). · DOI
  67. Califf, R. M. et al. Myonecrosis after revascularization procedures. J. Am. Coll. Cardiol. 31, 241–251 (1998). · DOI · Paper page
  68. White, H. D. The prequel. Defining prognostically important criteria in the periprocedural PCI troponin saga. Circ. Cardiovasc. Interv. 5, 142–145 (2012). · DOI
  69. Jaffe, A. S., Apple, F. S., Lindahl, B., Mueller, C. & Katus, H. A. Why all the struggle about CK-MB and PCI? Eur. Heart J. 33, 1046–1048 (2012). · DOI
  70. Damman, P. et al. Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR). Circulation 125, 568–576 (2012). · DOI
  71. Bonaca, M. P. et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal Definition of Myocardial Infarction Classification System and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel—Thrombolysis in Myocardial Infarction 38). Circulation 125, 577–583 (2012). · DOI · Paper page
  72. Cutlip, D. E. et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115, 2344–2351 (2007). · DOI · Paper page
  73. Benoit, M. O., Paris, M., Silleran, J., Fiemeyer, A. & Moatti, N. Cardiac troponin I: its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery. Crit. Care Med. 29, 1880–1886 (2001). · DOI
  74. Kovacevic, R. et al. Troponin T levels in detection of perioperative myocardial infarction after coronary artery bypass surgery. Clin. Lab. 50, 437–445 (2004).
  75. Noora, J., Ricci, C., Hastings, D., Hills, S. & Cybulsky, I. Determination of troponin I release after CABG surgery. J. Card. Surg. 20, 129–135 (2005). · DOI
  76. Selvanayagam, J. B. et al. Relationship of irreversible myocardial injury to troponin I and creatine kinase-MB elevation after coronary artery bypass surgery: insights from cardiovascular magnetic resonance imaging. J. Am. Coll. Cardiol. 45, 629–631 (2005). · DOI
  77. Costa, M. A. et al. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the Arterial Revascularization Therapies Study (ARTS). Circulation 104, 2689–2693 (2001). · DOI · Paper page
  78. Klatte, K. et al. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release. J. Am. Coll. Cardiol. 38, 1070–1077 (2001). · DOI
  79. Brener, S. J., Lytle, B. W., Schneider, J. P., Ellis, S. G. & Topol, E. J. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J. Am. Coll. Cardiol. 40, 1961–1967 (2002). · DOI · Paper page
  80. Domanski, M. et al. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 305, 585–589 (2011). · DOI · Paper page
  81. Croal, B. L. et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 114, 1468–1475 (2006). · DOI
  82. Selvanayagam, J. B. et al. Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation 109, 345–350 (2004). · DOI
  83. Leon, M. B. et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur. Heart J. 32, 205–217; J. Am. Coll. Cardiol. 57, 253–269 (2011). · DOI · Paper page
  84. Devereaux, P. J. et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann. Intern. Med. 154, 523–528 (2011). · DOI · Paper page
  85. The Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 307, 2295–2304 (2012). · DOI · Paper page
  86. Kavsak, P. A. et al. High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: a prospective cohort study. Clin. Biochem. 44, 1021–1024 (2011). · DOI
  87. Fleisher, L. A., Nelson, A. H. & Rosenbaum, S. H. Postoperative myocardial ischemia: etiology of cardiac morbidity or manifestation of underlying disease? J. Clin. Anesth. 7, 97–102 (1995). · DOI
  88. Landesberg, G. et al. Cardiac troponin after major vascular surgery: the role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization. J. Am. Coll. Cardiol. 44, 569–575 (2004). · DOI
  89. Cohen, M. C. & Aretz, T. H. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc. Pathol. 8, 133–139 (1999). · DOI · Paper page
  90. Guest, T. M. et al. Myocardial injury in critically ill medical patients: a surprisingly frequent complication. JAMA 273, 1945–1949 (1995). · DOI · Paper page
  91. Babuin, L. et al. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit. Care Med. 36, 759–765 (2008). · DOI
  92. Landesberg, G. et al. Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients. Crit. Care Med. 33, 1281–1287 (2005). · DOI
  93. Thygesen, K., Alpert, J. S., Jaffe, A. S. & White, H. D. Diagnostic application of the universal definition of myocardial infarction in the intensive care unit. Curr. Opin. Crit. Care 14, 543–548 (2008). · DOI
  94. Kociol, R. D. et al. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J. Am. Coll. Cardiol. 56, 1071–1078 (2010). · DOI · Paper page
  95. Januzzi, J. L. Jr, Filippatos, G., Nieminen, M. & Gheorghiade, M. Troponin elevation in patients with heart failure: on behalf of the Third Universal Task Force for the Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/ehs191 . · DOI · Paper page
  96. Miller, W. L., Hartman, K. A., Burritt, M. F., Grill, D. E. & Jaffe, A. S. Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J. Am. Coll. Cardiol. 54, 1715–1721 (2009). · DOI
  97. Dangas, G. D. et al. In-stent restenosis in the drug-eluting era. J. Am. Coll. Cardiol. 56, 1897–1907 (2010). · DOI · Paper page
  98. White, H. D. et al. Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort. Am. Heart J. 163, 563–571 (2012). · DOI
  99. Rosamond, W. et al. Twenty-two year trends in incidence of myocardial infarction, CHD mortality, and case-fatality in four US communities, 1987 to 2008. Circulation 125, 1848–1857 (2012). · DOI · Paper page
  100. Luepker, R., Duval, S., Jacobs, D., Smith, L. & Berger, A. The effect of changing diagnostic algorithms on acute myocardial infarction rates. Ann. Epidemiol. 21, 824–829 (2011). · DOI

Cited by

See all 2,053

Metadata

Authors
the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D.
Venue
Nature Reviews Cardiology
Publisher
Springer Science and Business Media LLC
Published
2012-08-25
Volume
9
Issue
11
Pages
620-633
ISSN
  • 1759-5002 (ISSN-L)
  • 1759-5010
DOI
10.1038/nrcardio.2012.122
OpenAlex
W2099869131
Cited by
2,053
References
2
FWCI
16.45
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Third universal definition of myocardial infarction. https://app.cochat.ai/papers/10.1038/nrcardio.2012.122
The paper
the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D. (2012). Third universal definition of myocardial infarction. Nature Reviews Cardiology. https://doi.org/10.1038/nrcardio.2012.122

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.